In-licensing: Seeking Late Stage/launched CNS Products, Specifically Indicated For Parkinson’s Disease, Dementia, Bi-polar Disorder And Addiction.

Latest: Watch here for details of new products and services.

About Us: Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs
Contact Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd

In-licensing
View

Seeking late stage/launched CNS products, specifically indicated for Parkinson’s disease, dementia, bi-polar disorder and addiction.

Our Spanish based company is looking to acquire late stage or launched CNS products particularly in the areas of Parkinson disease, addiction, bi-polar disorder and schizophrenia.

Full description

Our Spanish based company seeks to acquire late stage CNS products to add to its portfolio. The company is interested in products that treat degenerative and psychiatric disorders such as Parkinson's disease, Alzheimer's disease, bi-polar disorder and schizophrenia. The company has the sales and marketing capabilities to sell this product in the Spanish market.

Development status

Registered

Type of business relationship sought

In-licensing agreements or acquisition.

Licensing contact

Contact directly

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Unichem Laboratories Ltd. India seeks opportunities for in-licensing of NDDS and regular versions of pharmaceutical formulations for the high potential Indian market

Products for CNS disorders

OTC products for smoking cessation

Seeking to in-license late stage or marketed products for commercialization though Solvay’s strong commercial presence in emerging markets.

Related categories

Therapeutic target: Central Nervous System / Psychiatric / Addiction; Central Nervous System / Neurodegenerative disorders / Alzheimer's disease; Central Nervous System / Psychiatric / Bipolar disorder; Central Nervous System; Central Nervous System / Neurodegenerative disorders; Central Nervous System / Neurodegenerative disorders / Parkinson's disease; Central Nervous System / Psychiatric; Central Nervous System / Psychiatric / Schizophrenia

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Pharmalicensing current industry press releases.

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us